Potassium-sparing diuretic

2 marketed 1 in Phase 2

This page covers all Potassium-sparing diuretic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Epithelial sodium channel (ENaC), Amiloride-sensitive sodium channel, ENaC.

Targets

Epithelial sodium channel (ENaC) · Amiloride-sensitive sodium channel, ENaC

Marketed (2)

Phase 2 pipeline (1)